Vertex Pharmaceuticals (VRTX) Q4 2025 Earnings

3NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
3.98
4.25
4.53
4.8

Details

Expected EPS
4.573215
Actual EPS
4.8
Surprise EPS
0.23
Surprise Percent
+4.96%

Description

Vertex Pharmaceuticals (VRTX) has reported earnings of 4.8 per share for Q4 2025.

0 Comments

Share your thoughts